DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
34. 神経線維腫症
Neurofibromatosis
Clinical trials
/
Disease details
臨床試験数
:
133
/
薬物数
:
186
- (
DrugBank
:
67
) /
標的遺伝子数
:
79
-
標的パスウェイ数
:
190
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
JPRN-JapicCTI-194999
15/10/2019
14/10/2019
BeatNF2 trial
A Randomized Double-blind Multicenter trial to Assess the Efficacy and Safety of Bevacizumab for Neurofibromatosis Type 2
A Randomized Double-blind Multicenter trial to Assess the Efficacy and Safety of Bevacizumab for Neu ...
Neurofibromatosis type 2
Intervention name :
Bevacizumab
(Genitical Recombination)
INN of the intervention :
Bevacizumab
(Genitical Recombination)
Dosage And administration of the intervention : 5mg/kg in a total volume of 100ml, div, every 2 week
Control intervention name :
Isotonic sodium
chloride
solution
INN of the control intervention : -
Dosage And administration of the control intervention : 100ml, div
Intervention name :
Bevacizumab
(Genitical Recombination)
INN of the intervention :
Bevacizumab
(Geniti
...
Kiyoshi Saito
Masazumi Fujii, Masao Kobayakawa, Akihiro Inano, Jun Sakuma, Taku Sato, Akio Morita, Mitsuhiro Hasegawa, Takafumi Mitsuhara, Takashi Tamiya, Takeo Goro, Shigeru Yamaguchi, Hirofumi Nakatomi, Soichi Oya
Masazumi Fujii, Masao Kobayakawa, Akihiro Inano, Jun Sakuma, Taku Sato, Akio Morita, Mitsuhiro Haseg ...
pending
18
64
BOTH
60
Phase 2
Japan